Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin in...
Q2 2026
Aug 6, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 4, 2025